Colfosceril Polmitate

Colfosceril Polmitate is a synthetic surfactant used primarily in the treatment of neonatal respiratory distress syndrome (RDS). It helps to reduce surface tension in the lungs, facilitating better lung expansion and oxygenation.

Indications

Neonatal Respiratory Distress Syndrome (RDS)

Dosage

The dosage is typically administered intratracheally by a healthcare professional. The exact dose and frequency depend on the patient's condition and response to treatment.

Contra-Indications

-Hypersensitivity to Colfosceril Polmitate or any component of the formulation. -Severe pulmonary hemorrhage.

Special Precautions

-Use with caution in patients with a history of pulmonary hemorrhage or who are at risk for it. -Monitor for signs of adverse reactions, such as airway obstruction or changes in oxygenation.

Side Effects

-Possible side effects include mild fever, transient hypoxemia, and occasional pneumothorax. -Rare but serious side effects may include severe pulmonary hemorrhage.

Drug Interactions

Colfosceril Polmitate may interact with other medications administered concurrently. Ensure to discuss all ongoing treatments with your healthcare provider to avoid potential interactions.